Structure

Physi-Chem Properties

Molecular Weight:  646.39
Volume:  684.677
LogP:  7.104
LogD:  5.397
LogS:  -5.046
# Rotatable Bonds:  5
TPSA:  73.59
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  10
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.182
Synthetic Accessibility Score:  6.389
Fsp3:  0.537
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.652
MDCK Permeability:  1.2963702829438262e-05
Pgp-inhibitor:  0.992
Pgp-substrate:  0.994
Human Intestinal Absorption (HIA):  0.012
20% Bioavailability (F20%):  0.822
30% Bioavailability (F30%):  0.96

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.484
Plasma Protein Binding (PPB):  92.80281829833984%
Volume Distribution (VD):  1.744
Pgp-substrate:  4.887563228607178%

ADMET: Metabolism

CYP1A2-inhibitor:  0.063
CYP1A2-substrate:  0.975
CYP2C19-inhibitor:  0.422
CYP2C19-substrate:  0.947
CYP2C9-inhibitor:  0.155
CYP2C9-substrate:  0.539
CYP2D6-inhibitor:  0.888
CYP2D6-substrate:  0.925
CYP3A4-inhibitor:  0.754
CYP3A4-substrate:  0.938

ADMET: Excretion

Clearance (CL):  4.307
Half-life (T1/2):  0.071

ADMET: Toxicity

hERG Blockers:  0.979
Human Hepatotoxicity (H-HT):  0.716
Drug-inuced Liver Injury (DILI):  0.866
AMES Toxicity:  0.237
Rat Oral Acute Toxicity:  0.991
Maximum Recommended Daily Dose:  0.998
Skin Sensitization:  0.064
Carcinogencity:  0.314
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.982

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC478082

Natural Product ID:  NPC478082
Common Name*:   MCJPACZBPWHLOV-RVPUSWGPSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  MCJPACZBPWHLOV-RVPUSWGPSA-N
Standard InCHI:  InChI=1S/C41H50N4O3/c1-6-23-14-22-15-32-38-26(12-13-45(20-22)40(23)32)28-19-36(47-4)29(17-34(28)43-38)30-16-27-24(7-2)21-44(3)35(37(27)41(46)48-5)18-31-25-10-8-9-11-33(25)42-39(30)31/h7-11,17,19,22-23,27,30,32,35,37,40,42-43H,6,12-16,18,20-21H2,1-5H3/b24-7-/t22-,23-,27+,30+,32-,35-,37-,40-/m0/s1
SMILES:  CC[C@H]1C[C@@H]2CN3[C@@H]1[C@@H](C2)c1[nH]c2c(c1CC3)cc(c(c2)[C@H]1C[C@@H]2/C(=CC)/CN([C@H]([C@H]2C(=O)OC)Cc2c1[nH]c1c2cccc1)C)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3581905
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0002748] Ibogan-type alkaloids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[18778099]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. leaf n.a. PMID[18778099]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota Leaves n.a. n.a. PMID[24773071]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota stem-bark Pahang, Malaysia 2003-JUN PMID[25919190]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[26918761]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[27077800]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[29319316]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[30869890]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[32356659]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 800.0 nM PMID[564988]
NPT91 Cell Line KB Homo sapiens IC50 = 980.0 nM PMID[564988]
NPT91 Cell Line KB Homo sapiens IC50 = 1530.0 nM PMID[564988]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 2800.0 nM PMID[564989]
NPT858 Cell Line LNCaP Homo sapiens IC50 > 10000.0 nM PMID[564989]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 6000.0 nM PMID[564989]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 2500.0 nM PMID[564989]
NPT81 Cell Line A549 Homo sapiens IC50 = 6800.0 nM PMID[564989]
NPT393 Cell Line HCT-116 Homo sapiens IC50 = 1600.0 nM PMID[564989]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 930.0 nM PMID[564989]
NPT2 Others Unspecified IC50 = 5300.0 nM PMID[564989]
NPT22764 CELL-LINE KB/VJ300 Homo sapiens IC50 = 5000.0 nM PMID[564989]
NPT22764 CELL-LINE KB/VJ300 Homo sapiens IC50 = 7000.0 nM PMID[564989]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC478082 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC477067
0.986 High Similarity NPC477066
0.9816 High Similarity NPC17437
0.9814 High Similarity NPC478081
0.9378 High Similarity NPC478080
0.9193 High Similarity NPC81939
0.9189 High Similarity NPC473540
0.9152 High Similarity NPC475666
0.9083 High Similarity NPC478083
0.8796 High Similarity NPC96321
0.8645 High Similarity NPC471304
0.8527 High Similarity NPC311906
0.8505 High Similarity NPC477065
0.844 Intermediate Similarity NPC478074
0.8371 Intermediate Similarity NPC473041
0.8333 Intermediate Similarity NPC475720
0.8333 Intermediate Similarity NPC474192
0.8333 Intermediate Similarity NPC471303
0.831 Intermediate Similarity NPC329793
0.8281 Intermediate Similarity NPC469928
0.8238 Intermediate Similarity NPC478078
0.8201 Intermediate Similarity NPC329982
0.8133 Intermediate Similarity NPC472099
0.812 Intermediate Similarity NPC475816
0.8117 Intermediate Similarity NPC152768
0.8117 Intermediate Similarity NPC148183
0.8063 Intermediate Similarity NPC472098
0.7983 Intermediate Similarity NPC473105
0.7922 Intermediate Similarity NPC470126
0.789 Intermediate Similarity NPC329747
0.7888 Intermediate Similarity NPC253580
0.7876 Intermediate Similarity NPC330009
0.786 Intermediate Similarity NPC280799
0.7857 Intermediate Similarity NPC208284
0.7841 Intermediate Similarity NPC305984
0.7803 Intermediate Similarity NPC475910
0.7793 Intermediate Similarity NPC300156
0.7768 Intermediate Similarity NPC476116
0.7759 Intermediate Similarity NPC21638
0.7749 Intermediate Similarity NPC280272
0.7727 Intermediate Similarity NPC469734
0.7665 Intermediate Similarity NPC473180
0.7665 Intermediate Similarity NPC94157
0.766 Intermediate Similarity NPC314954
0.7647 Intermediate Similarity NPC39370
0.7639 Intermediate Similarity NPC329858
0.7637 Intermediate Similarity NPC473186
0.7631 Intermediate Similarity NPC284685
0.7626 Intermediate Similarity NPC237901
0.7626 Intermediate Similarity NPC195788
0.7617 Intermediate Similarity NPC157931
0.7595 Intermediate Similarity NPC477531
0.7595 Intermediate Similarity NPC475253
0.7586 Intermediate Similarity NPC477533
0.7585 Intermediate Similarity NPC33949
0.7585 Intermediate Similarity NPC252251
0.7574 Intermediate Similarity NPC227908
0.7568 Intermediate Similarity NPC249040
0.7565 Intermediate Similarity NPC183407
0.7556 Intermediate Similarity NPC45190
0.7553 Intermediate Similarity NPC209174
0.7552 Intermediate Similarity NPC41679
0.7542 Intermediate Similarity NPC295228
0.7532 Intermediate Similarity NPC476041
0.7532 Intermediate Similarity NPC304926
0.753 Intermediate Similarity NPC191489
0.7511 Intermediate Similarity NPC86078
0.751 Intermediate Similarity NPC260909
0.75 Intermediate Similarity NPC131017
0.75 Intermediate Similarity NPC162730
0.7489 Intermediate Similarity NPC170114
0.748 Intermediate Similarity NPC315634
0.748 Intermediate Similarity NPC100734
0.748 Intermediate Similarity NPC88923
0.7477 Intermediate Similarity NPC314333
0.7468 Intermediate Similarity NPC473185
0.7467 Intermediate Similarity NPC223427
0.7467 Intermediate Similarity NPC162484
0.7456 Intermediate Similarity NPC201697
0.7446 Intermediate Similarity NPC470549
0.7445 Intermediate Similarity NPC4687
0.7445 Intermediate Similarity NPC193777
0.7442 Intermediate Similarity NPC176127
0.7436 Intermediate Similarity NPC132642
0.7425 Intermediate Similarity NPC46561
0.7425 Intermediate Similarity NPC303658
0.7424 Intermediate Similarity NPC199667
0.7422 Intermediate Similarity NPC474116
0.7404 Intermediate Similarity NPC60621
0.7404 Intermediate Similarity NPC477532
0.7403 Intermediate Similarity NPC469592
0.7403 Intermediate Similarity NPC471080
0.7401 Intermediate Similarity NPC472111
0.7397 Intermediate Similarity NPC473187
0.7389 Intermediate Similarity NPC476098
0.7382 Intermediate Similarity NPC169402
0.738 Intermediate Similarity NPC473181
0.7373 Intermediate Similarity NPC144452
0.7371 Intermediate Similarity NPC116238
0.7366 Intermediate Similarity NPC184680
0.7359 Intermediate Similarity NPC264176
0.7357 Intermediate Similarity NPC285558
0.7352 Intermediate Similarity NPC111602
0.7352 Intermediate Similarity NPC196251
0.7352 Intermediate Similarity NPC102338
0.7352 Intermediate Similarity NPC63199
0.7348 Intermediate Similarity NPC126066
0.7344 Intermediate Similarity NPC469554
0.7344 Intermediate Similarity NPC101543
0.7342 Intermediate Similarity NPC276517
0.7341 Intermediate Similarity NPC53534
0.7336 Intermediate Similarity NPC470784
0.7336 Intermediate Similarity NPC470785
0.7333 Intermediate Similarity NPC176538
0.7328 Intermediate Similarity NPC39500
0.7322 Intermediate Similarity NPC6215
0.7319 Intermediate Similarity NPC473179
0.7316 Intermediate Similarity NPC87413
0.7303 Intermediate Similarity NPC474688
0.7301 Intermediate Similarity NPC267423
0.7295 Intermediate Similarity NPC15801
0.7292 Intermediate Similarity NPC471762
0.7285 Intermediate Similarity NPC92111
0.7284 Intermediate Similarity NPC475778
0.7284 Intermediate Similarity NPC48353
0.728 Intermediate Similarity NPC202503
0.7277 Intermediate Similarity NPC469594
0.7276 Intermediate Similarity NPC81175
0.7273 Intermediate Similarity NPC167860
0.7273 Intermediate Similarity NPC123976
0.7269 Intermediate Similarity NPC322482
0.7265 Intermediate Similarity NPC74969
0.7265 Intermediate Similarity NPC101350
0.7257 Intermediate Similarity NPC294909
0.7257 Intermediate Similarity NPC254240
0.7257 Intermediate Similarity NPC312870
0.7257 Intermediate Similarity NPC128265
0.7257 Intermediate Similarity NPC199851
0.7255 Intermediate Similarity NPC89549
0.7252 Intermediate Similarity NPC55493
0.7251 Intermediate Similarity NPC133609
0.7247 Intermediate Similarity NPC473312
0.7244 Intermediate Similarity NPC72211
0.7241 Intermediate Similarity NPC9894
0.724 Intermediate Similarity NPC469497
0.724 Intermediate Similarity NPC106833
0.724 Intermediate Similarity NPC76748
0.7237 Intermediate Similarity NPC152620
0.7233 Intermediate Similarity NPC303374
0.7227 Intermediate Similarity NPC162748
0.7224 Intermediate Similarity NPC473183
0.7224 Intermediate Similarity NPC6786
0.7224 Intermediate Similarity NPC235685
0.7222 Intermediate Similarity NPC189079
0.722 Intermediate Similarity NPC307963
0.722 Intermediate Similarity NPC274640
0.7217 Intermediate Similarity NPC53344
0.7217 Intermediate Similarity NPC249583
0.7217 Intermediate Similarity NPC321428
0.7215 Intermediate Similarity NPC174760
0.721 Intermediate Similarity NPC308137
0.721 Intermediate Similarity NPC310211
0.7203 Intermediate Similarity NPC184408
0.72 Intermediate Similarity NPC243834
0.72 Intermediate Similarity NPC70956
0.7198 Intermediate Similarity NPC234999
0.7195 Intermediate Similarity NPC296527
0.7195 Intermediate Similarity NPC131486
0.7195 Intermediate Similarity NPC128751
0.7185 Intermediate Similarity NPC198503
0.7181 Intermediate Similarity NPC195461
0.7181 Intermediate Similarity NPC249150
0.7181 Intermediate Similarity NPC49196
0.7181 Intermediate Similarity NPC81654
0.7181 Intermediate Similarity NPC313985
0.7181 Intermediate Similarity NPC79129
0.7178 Intermediate Similarity NPC257851
0.7173 Intermediate Similarity NPC193267
0.7173 Intermediate Similarity NPC213530
0.7168 Intermediate Similarity NPC52557
0.7166 Intermediate Similarity NPC477861
0.7162 Intermediate Similarity NPC472112
0.7156 Intermediate Similarity NPC245916
0.7156 Intermediate Similarity NPC70259
0.7149 Intermediate Similarity NPC194740
0.7149 Intermediate Similarity NPC21425
0.7149 Intermediate Similarity NPC476044
0.7149 Intermediate Similarity NPC66777
0.7143 Intermediate Similarity NPC323969
0.7143 Intermediate Similarity NPC225279
0.7143 Intermediate Similarity NPC473184
0.7143 Intermediate Similarity NPC150239
0.7137 Intermediate Similarity NPC24370
0.7137 Intermediate Similarity NPC319232
0.7137 Intermediate Similarity NPC241024
0.713 Intermediate Similarity NPC475070
0.7124 Intermediate Similarity NPC475422
0.7117 Intermediate Similarity NPC246700
0.7114 Intermediate Similarity NPC477549
0.7112 Intermediate Similarity NPC39679

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478082 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9816 High Similarity NPD8358 Approved
0.8263 Intermediate Similarity NPD4118 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD8017 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD8016 Phase 3
0.7809 Intermediate Similarity NPD8364 Approved
0.7809 Intermediate Similarity NPD8363 Approved
0.7787 Intermediate Similarity NPD4885 Approved
0.7747 Intermediate Similarity NPD8365 Clinical (unspecified phase)
0.7631 Intermediate Similarity NPD7955 Approved
0.7631 Intermediate Similarity NPD7956 Approved
0.7626 Intermediate Similarity NPD8465 Approved
0.7626 Intermediate Similarity NPD8466 Approved
0.7626 Intermediate Similarity NPD8467 Approved
0.7577 Intermediate Similarity NPD8426 Approved
0.7577 Intermediate Similarity NPD8425 Approved
0.7566 Intermediate Similarity NPD5658 Approved
0.7558 Intermediate Similarity NPD8429 Approved
0.7558 Intermediate Similarity NPD8427 Approved
0.7558 Intermediate Similarity NPD8428 Approved
0.7532 Intermediate Similarity NPD7823 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD7708 Approved
0.751 Intermediate Similarity NPD8460 Approved
0.751 Intermediate Similarity NPD8459 Approved
0.748 Intermediate Similarity NPD7803 Approved
0.7477 Intermediate Similarity NPD4499 Approved
0.7469 Intermediate Similarity NPD5483 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD5488 Discontinued
0.7436 Intermediate Similarity NPD6242 Discontinued
0.7373 Intermediate Similarity NPD7221 Approved
0.7373 Intermediate Similarity NPD6160 Clinical (unspecified phase)
0.7373 Intermediate Similarity NPD7219 Approved
0.7368 Intermediate Similarity NPD8100 Phase 3
0.735 Intermediate Similarity NPD5632 Approved
0.7344 Intermediate Similarity NPD7797 Approved
0.7344 Intermediate Similarity NPD7796 Approved
0.7342 Intermediate Similarity NPD4418 Discontinued
0.7325 Intermediate Similarity NPD8403 Phase 1
0.7325 Intermediate Similarity NPD5530 Phase 1
0.7322 Intermediate Similarity NPD7268 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD6824 Clinical (unspecified phase)
0.728 Intermediate Similarity NPD8101 Phase 3
0.7265 Intermediate Similarity NPD3324 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD2916 Discontinued
0.7261 Intermediate Similarity NPD5479 Discontinued
0.7257 Intermediate Similarity NPD4501 Approved
0.7257 Intermediate Similarity NPD4500 Approved
0.7244 Intermediate Similarity NPD4987 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD6567 Clinical (unspecified phase)
0.7236 Intermediate Similarity NPD2921 Clinical (unspecified phase)
0.722 Intermediate Similarity NPD1038 Approved
0.722 Intermediate Similarity NPD1304 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD7452 Approved
0.7217 Intermediate Similarity NPD7453 Approved
0.7217 Intermediate Similarity NPD7222 Phase 2
0.7211 Intermediate Similarity NPD5482 Discontinued
0.7206 Intermediate Similarity NPD7417 Discontinued
0.7206 Intermediate Similarity NPD8489 Phase 1
0.7188 Intermediate Similarity NPD6531 Approved
0.7188 Intermediate Similarity NPD6530 Approved
0.7181 Intermediate Similarity NPD4601 Approved
0.7181 Intermediate Similarity NPD4600 Approved
0.7176 Intermediate Similarity NPD8091 Phase 3
0.7174 Intermediate Similarity NPD3003 Approved
0.7173 Intermediate Similarity NPD7194 Discontinued
0.7167 Intermediate Similarity NPD7470 Discontinued
0.7149 Intermediate Similarity NPD7710 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5429 Discontinued
0.713 Intermediate Similarity NPD4795 Phase 2
0.7126 Intermediate Similarity NPD8463 Approved
0.7119 Intermediate Similarity NPD3393 Approved
0.7119 Intermediate Similarity NPD3394 Approved
0.7119 Intermediate Similarity NPD6969 Phase 2
0.7119 Intermediate Similarity NPD6968 Phase 2
0.7119 Intermediate Similarity NPD3389 Approved
0.7117 Intermediate Similarity NPD8524 Approved
0.7115 Intermediate Similarity NPD6503 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD3006 Discontinued
0.7111 Intermediate Similarity NPD6861 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD484 Approved
0.7103 Intermediate Similarity NPD4558 Phase 2
0.7103 Intermediate Similarity NPD8102 Discontinued
0.7102 Intermediate Similarity NPD5040 Clinical (unspecified phase)
0.7102 Intermediate Similarity NPD6741 Clinical (unspecified phase)
0.7094 Intermediate Similarity NPD5416 Discontinued
0.7078 Intermediate Similarity NPD5559 Phase 2
0.7076 Intermediate Similarity NPD7538 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD5293 Phase 2
0.7071 Intermediate Similarity NPD5930 Phase 3
0.7059 Intermediate Similarity NPD3354 Phase 2
0.7049 Intermediate Similarity NPD4952 Phase 3
0.7049 Intermediate Similarity NPD7589 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD5003 Discontinued
0.704 Intermediate Similarity NPD7392 Phase 2
0.7039 Intermediate Similarity NPD2510 Approved
0.7039 Intermediate Similarity NPD2509 Approved
0.7037 Intermediate Similarity NPD7994 Phase 2
0.7029 Intermediate Similarity NPD3402 Phase 1
0.7029 Intermediate Similarity NPD3763 Approved
0.702 Intermediate Similarity NPD7688 Phase 1
0.7018 Intermediate Similarity NPD7889 Clinical (unspecified phase)
0.7004 Intermediate Similarity NPD5902 Approved
0.7004 Intermediate Similarity NPD3257 Approved
0.7004 Intermediate Similarity NPD5903 Approved
0.7004 Intermediate Similarity NPD5417 Clinical (unspecified phase)
0.6996 Remote Similarity NPD6276 Discontinued
0.6996 Remote Similarity NPD6838 Clinical (unspecified phase)
0.6996 Remote Similarity NPD7868 Clinical (unspecified phase)
0.6992 Remote Similarity NPD7069 Discontinued
0.6988 Remote Similarity NPD7729 Clinical (unspecified phase)
0.6987 Remote Similarity NPD7395 Discontinued
0.6983 Remote Similarity NPD4036 Approved
0.6983 Remote Similarity NPD4122 Approved
0.6983 Remote Similarity NPD4039 Approved
0.6983 Remote Similarity NPD4033 Approved
0.6983 Remote Similarity NPD4035 Approved
0.6983 Remote Similarity NPD4037 Approved
0.6983 Remote Similarity NPD4034 Approved
0.6983 Remote Similarity NPD7548 Discontinued
0.6983 Remote Similarity NPD32 Approved
0.6983 Remote Similarity NPD31 Approved
0.6983 Remote Similarity NPD4038 Approved
0.6983 Remote Similarity NPD3946 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6344 Clinical (unspecified phase)
0.698 Remote Similarity NPD8052 Clinical (unspecified phase)
0.6975 Remote Similarity NPD5612 Discontinued
0.697 Remote Similarity NPD5669 Clinical (unspecified phase)
0.6964 Remote Similarity NPD7558 Phase 2
0.6964 Remote Similarity NPD4373 Phase 2
0.696 Remote Similarity NPD7025 Clinical (unspecified phase)
0.6958 Remote Similarity NPD3258 Approved
0.6957 Remote Similarity NPD1740 Approved
0.6957 Remote Similarity NPD1739 Approved
0.6957 Remote Similarity NPD4396 Clinical (unspecified phase)
0.6949 Remote Similarity NPD8525 Approved
0.6942 Remote Similarity NPD7690 Clinical (unspecified phase)
0.693 Remote Similarity NPD5512 Phase 3
0.6926 Remote Similarity NPD7426 Phase 1
0.6926 Remote Similarity NPD7603 Discontinued
0.6926 Remote Similarity NPD4926 Clinical (unspecified phase)
0.692 Remote Similarity NPD4442 Phase 2
0.692 Remote Similarity NPD3816 Phase 1
0.692 Remote Similarity NPD3815 Phase 1
0.692 Remote Similarity NPD6773 Clinical (unspecified phase)
0.6917 Remote Similarity NPD4429 Discontinued
0.6917 Remote Similarity NPD8405 Clinical (unspecified phase)
0.6917 Remote Similarity NPD6985 Discontinued
0.6917 Remote Similarity NPD6230 Discontinued
0.6913 Remote Similarity NPD6661 Clinical (unspecified phase)
0.6913 Remote Similarity NPD1768 Approved
0.6913 Remote Similarity NPD8396 Approved
0.6913 Remote Similarity NPD8395 Approved
0.6908 Remote Similarity NPD5891 Approved
0.6903 Remote Similarity NPD5912 Clinical (unspecified phase)
0.6903 Remote Similarity NPD5913 Phase 3
0.6901 Remote Similarity NPD5506 Approved
0.6901 Remote Similarity NPD5507 Approved
0.6894 Remote Similarity NPD2189 Approved
0.6894 Remote Similarity NPD2187 Approved
0.6892 Remote Similarity NPD5522 Clinical (unspecified phase)
0.6891 Remote Similarity NPD7571 Clinical (unspecified phase)
0.6888 Remote Similarity NPD6770 Approved
0.6882 Remote Similarity NPD5450 Discontinued
0.688 Remote Similarity NPD4862 Clinical (unspecified phase)
0.6878 Remote Similarity NPD8013 Clinical (unspecified phase)
0.6877 Remote Similarity NPD7592 Phase 2
0.6875 Remote Similarity NPD6243 Phase 3
0.6875 Remote Similarity NPD6244 Phase 3
0.6875 Remote Similarity NPD3440 Clinical (unspecified phase)
0.6872 Remote Similarity NPD6995 Phase 1
0.6865 Remote Similarity NPD6790 Phase 1
0.686 Remote Similarity NPD7678 Clinical (unspecified phase)
0.686 Remote Similarity NPD5070 Clinical (unspecified phase)
0.6856 Remote Similarity NPD7673 Phase 3
0.6846 Remote Similarity NPD8109 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5575 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5801 Clinical (unspecified phase)
0.684 Remote Similarity NPD3825 Phase 3
0.6838 Remote Similarity NPD6517 Phase 3
0.6838 Remote Similarity NPD6716 Phase 1
0.683 Remote Similarity NPD7924 Phase 2
0.683 Remote Similarity NPD7925 Phase 2
0.6828 Remote Similarity NPD6630 Clinical (unspecified phase)
0.6827 Remote Similarity NPD7790 Approved
0.6827 Remote Similarity NPD7951 Approved
0.6827 Remote Similarity NPD7950 Approved
0.6827 Remote Similarity NPD7791 Approved
0.6827 Remote Similarity NPD7789 Approved
0.6827 Remote Similarity NPD7952 Approved
0.6827 Remote Similarity NPD7953 Approved
0.6826 Remote Similarity NPD6769 Clinical (unspecified phase)
0.6822 Remote Similarity NPD6376 Discontinued
0.6816 Remote Similarity NPD6976 Clinical (unspecified phase)
0.6807 Remote Similarity NPD4502 Phase 2
0.68 Remote Similarity NPD6963 Approved
0.68 Remote Similarity NPD6964 Approved
0.6797 Remote Similarity NPD7946 Pre-registration
0.6794 Remote Similarity NPD6228 Discontinued
0.6792 Remote Similarity NPD4897 Phase 2
0.6789 Remote Similarity NPD7051 Phase 3
0.6789 Remote Similarity NPD7050 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data